ASTH vs URGN

Comparison between Apollo Medical Holdings Inc (ASTH, Company) and UroGen Pharma Ltd (URGN, Company).

Both ASTH and URGN are from the Healthcare sector.

5-Year PerformanceURGN has outperformed ASTH, delivering a return of +22.7% compared to -18.3%

ASTH vs URGN - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	ASTH(COMPANY)	URGN(COMPANY)
Market Cap	$2.05B	$2.05B
Max Drawdown	84.80%	93.98%
Sharpe Ratio	1.10	1.66
5Y Beta	0.61	1.18
Industry	Medical Care Facilities	Biotechnology
P/E Ratio	67.98	-14.90
Forward P/E	23.04	N/A
PEG Ratio	0.00	-0.09
5Y EPS CAGR	-8.24%	-11.74%
Debt to Equity	128.41%	-152.54%
Free Cash Flow Yield	7.55%	-8.10%
P/S Ratio	0.59	14.59
P/B Ratio	2.82	19.27

Market Cap

Winner

ASTH

$2.05B

URGN

$2.05B

Max Drawdown

Winner

ASTH

84.80%

URGN

93.98%

Sharpe Ratio

ASTH

1.10

Winner

URGN

1.66

5Y Beta

Winner

ASTH

0.61

URGN

1.18

Industry

ASTH

Medical Care Facilities

URGN

Biotechnology

P/E Ratio

ASTH

67.98

Winner

URGN

-14.90

Forward P/E

ASTH

23.04

URGN

N/A

PEG Ratio

ASTH

0.00

Winner

URGN

-0.09

5Y EPS CAGR

Winner

ASTH

-8.24%

URGN

-11.74%

Debt to Equity

ASTH

128.41%

Winner

URGN

-152.54%

Free Cash Flow Yield

Winner

ASTH

7.55%

URGN

-8.10%

P/S Ratio

Winner

ASTH

0.59

URGN

14.59

P/B Ratio

Winner

ASTH

2.82

URGN

19.27

ASTH vs URGN - Historical Returns

Returns include dividend reinvestment.

Period	ASTH	URGN
1 month	-0.51%	+20.91%
3 months	+24.48%	+74.83%
6 months	+50.92%	+112.50%
1 year	+74.87%	+127.76%
5 years(CAGR)	-18.34%	+22.67%
10 years(CAGR)	+22.24%	+12.82%
Max(CAGR)	+40.81%	+12.82%

ASTH

-0.51%

Winner

URGN

+20.91%

ASTH

+24.48%

Winner

URGN

+74.83%

ASTH

+50.92%

Winner

URGN

+112.50%

ASTH

+74.87%

Winner

URGN

+127.76%

5Y(CAGR)

ASTH

-18.34%

Winner

URGN

+22.67%

10Y(CAGR)

Winner

ASTH

+22.24%

URGN

+12.82%

Max(CAGR)

Winner

ASTH

+40.81%

URGN

+12.82%

ASTH vs URGN - Annual Returns (2011 - 2026)

Returns include dividend reinvestment.

Year	ASTH	URGN
2026	+62.53%	+87.14%
2025	-22.95%	+118.88%
2024	-18.70%	-29.98%
2023	+35.53%	+73.61%
2022	-55.86%	-8.84%
2021	+281.71%	-47.14%
2020	+0.27%	-44.67%
2019	-5.88%	-25.03%
2018	-17.29%	+11.44%
2017	+220.00%	+166.17%
2016	+57.89%	N/A
2015	+955.56%	N/A
2014	-30.77%	N/A
2013	+35.98%	N/A
2012	+242.94%	N/A
2011	-30.57%	N/A

ASTH vs URGN Drawdown Comparison

The maximum drawdown for ASTH was -84.80%, occurring on Feb 12, 2026. This drawdown has not yet recovered.

The maximum drawdown for URGN was -93.98%, occurring on May 27, 2025. This drawdown has not yet recovered.

The current ASTH drawdown is -65.68%. The current URGN drawdown is -34.95%.

Rank	ASTH	URGN
#1	-84.80% Nov 16, 2021 - Feb 12, 2026	-93.98% May 18, 2018 - May 27, 2025
#2	-83.35% May 1, 2015 - Jan 6, 2017	-20.07% May 30, 2017 - Jun 26, 2017
#3	-78.26% Dec 5, 2012 - Apr 29, 2015	-18.48% Jan 25, 2018 - Mar 5, 2018
#4	-76.82% Mar 30, 2011 - Jul 16, 2012	-16.63% Sep 14, 2017 - Nov 2, 2017
#5	-68.25% Jul 16, 2012 - Dec 5, 2012	-15.97% Mar 14, 2018 - Apr 3, 2018
#6	-68.17% Jun 22, 2018 - May 3, 2021	-14.93% Nov 13, 2017 - Jan 3, 2018
#7	-54.45% Jan 16, 2018 - Jun 22, 2018	-13.38% Jun 27, 2017 - Aug 30, 2017
#8	-43.18% May 31, 2017 - Dec 12, 2017	-11.40% Apr 4, 2018 - May 18, 2018
#9	-39.18% Jul 23, 2021 - Nov 15, 2021	-5.75% Jan 16, 2018 - Jan 22, 2018
#10	-21.95% Jan 12, 2017 - May 31, 2017	-4.09% May 16, 2017 - May 18, 2017
#11	-20.00% Jan 6, 2017 - Jan 12, 2017	-3.88% Jan 3, 2018 - Jan 16, 2018
#12	-18.18% Dec 13, 2017 - Dec 20, 2017	-3.19% May 11, 2017 - May 15, 2017
#13	-15.03% Jul 12, 2021 - Jul 21, 2021	-2.61% Mar 9, 2018 - Mar 14, 2018
#14	-12.95% Feb 23, 2011 - Mar 21, 2011	-2.59% May 22, 2017 - May 30, 2017
#15	-10.72% May 10, 2021 - May 24, 2021	-2.21% Sep 7, 2017 - Sep 12, 2017

Correlation

Correlation between ASTH and URGN is -0.47 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.

-0.47

-101